Photo
October 8, 2021
Dahiyat
Stories this photo appears in:
Xencor Inks Second Deal With Janssen Pharmaceuticals This Year
Monrovia-based biopharma company Xencor Inc. on Oct. 4 announced its second collaboration and license agreement with Janssen Biotech Inc. in 10 months — this one to develop and commercialize its drug candidate that stimulates T cells to treat certain types of lymphomas.
